Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).

Identifieur interne : 000296 ( PubMed/Corpus ); précédent : 000295; suivant : 000297

In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).

Auteurs : Phulen Sarma ; Nishant Sekhar ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Sanjay Singh ; Harish Kumar ; Ajay Prakash ; Deba Prasad Dhibar ; Bikash Medhi

Source :

RBID : pubmed:32266867

Abstract

The N terminal domain (NTD) of Nucleocapsid protein (N protein) of coronavirus (CoV) binds to the viral (+) sense RNA and results in CoV ribonucleoprotien (CoV RNP) complex, essential for the virus replication. In this study, the RNA-binding N terminal domain (NTD) of the N protein was targeted for the identification of possible inhibitors of RNA binding. Two NTD structures of N proteins were selected (2OFZ and 1SSK, 92% homology) for virtual screening of 56,079 compounds from Asinex and Maybridge library to identify top 15 hits for each of the targets based on "docking score". These top-hits were further screened for MM-GBSA binding free energy, pharmacokinetic properties (QikProp) and drug-likeness (SwissADME) and subjected to molecular dynamics (MD) studies. Two suitable binders (ZINC00003118440 and ZINC0000146942) against the target 2OFZ were identified. ZINC00003118440 is a theophylline derivative under the drug class 'bronchodilEtors' and further screening with approved bronchodilators was also studied to identify their ability to bind to the RNA binding region on the N protein. The other identified top hit is ZINC0000146942, which is a 3,4dihydropyrimidone class molecule. Hence this study suggests two important class of compounds, theophylline and pyrimidone derivaties as possible inhibitors of RNA binding to the N terminal domain of N protein of coronavirus, thus opening new avenues for in vitro validations.

DOI: 10.1080/07391102.2020.1753580
PubMed: 32266867

Links to Exploration step

pubmed:32266867

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).</title>
<author>
<name sortKey="Sarma, Phulen" sort="Sarma, Phulen" uniqKey="Sarma P" first="Phulen" last="Sarma">Phulen Sarma</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sekhar, Nishant" sort="Sekhar, Nishant" uniqKey="Sekhar N" first="Nishant" last="Sekhar">Nishant Sekhar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prajapat, Manisha" sort="Prajapat, Manisha" uniqKey="Prajapat M" first="Manisha" last="Prajapat">Manisha Prajapat</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Avti, Pramod" sort="Avti, Pramod" uniqKey="Avti P" first="Pramod" last="Avti">Pramod Avti</name>
<affiliation>
<nlm:affiliation>Department of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kaur, Hardeep" sort="Kaur, Hardeep" uniqKey="Kaur H" first="Hardeep" last="Kaur">Hardeep Kaur</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kumar, Subodh" sort="Kumar, Subodh" uniqKey="Kumar S" first="Subodh" last="Kumar">Subodh Kumar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Singh, Sanjay" sort="Singh, Sanjay" uniqKey="Singh S" first="Sanjay" last="Singh">Sanjay Singh</name>
<affiliation>
<nlm:affiliation>Biomedical Informatics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kumar, Harish" sort="Kumar, Harish" uniqKey="Kumar H" first="Harish" last="Kumar">Harish Kumar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prakash, Ajay" sort="Prakash, Ajay" uniqKey="Prakash A" first="Ajay" last="Prakash">Ajay Prakash</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhibar, Deba Prasad" sort="Dhibar, Deba Prasad" uniqKey="Dhibar D" first="Deba Prasad" last="Dhibar">Deba Prasad Dhibar</name>
<affiliation>
<nlm:affiliation>Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Medhi, Bikash" sort="Medhi, Bikash" uniqKey="Medhi B" first="Bikash" last="Medhi">Bikash Medhi</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32266867</idno>
<idno type="pmid">32266867</idno>
<idno type="doi">10.1080/07391102.2020.1753580</idno>
<idno type="wicri:Area/PubMed/Corpus">000296</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000296</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).</title>
<author>
<name sortKey="Sarma, Phulen" sort="Sarma, Phulen" uniqKey="Sarma P" first="Phulen" last="Sarma">Phulen Sarma</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sekhar, Nishant" sort="Sekhar, Nishant" uniqKey="Sekhar N" first="Nishant" last="Sekhar">Nishant Sekhar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prajapat, Manisha" sort="Prajapat, Manisha" uniqKey="Prajapat M" first="Manisha" last="Prajapat">Manisha Prajapat</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Avti, Pramod" sort="Avti, Pramod" uniqKey="Avti P" first="Pramod" last="Avti">Pramod Avti</name>
<affiliation>
<nlm:affiliation>Department of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kaur, Hardeep" sort="Kaur, Hardeep" uniqKey="Kaur H" first="Hardeep" last="Kaur">Hardeep Kaur</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kumar, Subodh" sort="Kumar, Subodh" uniqKey="Kumar S" first="Subodh" last="Kumar">Subodh Kumar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Singh, Sanjay" sort="Singh, Sanjay" uniqKey="Singh S" first="Sanjay" last="Singh">Sanjay Singh</name>
<affiliation>
<nlm:affiliation>Biomedical Informatics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kumar, Harish" sort="Kumar, Harish" uniqKey="Kumar H" first="Harish" last="Kumar">Harish Kumar</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prakash, Ajay" sort="Prakash, Ajay" uniqKey="Prakash A" first="Ajay" last="Prakash">Ajay Prakash</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhibar, Deba Prasad" sort="Dhibar, Deba Prasad" uniqKey="Dhibar D" first="Deba Prasad" last="Dhibar">Deba Prasad Dhibar</name>
<affiliation>
<nlm:affiliation>Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Medhi, Bikash" sort="Medhi, Bikash" uniqKey="Medhi B" first="Bikash" last="Medhi">Bikash Medhi</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of biomolecular structure & dynamics</title>
<idno type="eISSN">1538-0254</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The N terminal domain (NTD) of Nucleocapsid protein (N protein) of coronavirus (CoV) binds to the viral (+) sense RNA and results in CoV ribonucleoprotien (CoV RNP) complex, essential for the virus replication. In this study, the RNA-binding N terminal domain (NTD) of the N protein was targeted for the identification of possible inhibitors of RNA binding. Two NTD structures of N proteins were selected (2OFZ and 1SSK, 92% homology) for virtual screening of 56,079 compounds from Asinex and Maybridge library to identify top 15 hits for each of the targets based on "docking score". These top-hits were further screened for MM-GBSA binding free energy, pharmacokinetic properties (QikProp) and drug-likeness (SwissADME) and subjected to molecular dynamics (MD) studies. Two suitable binders (ZINC00003118440 and ZINC0000146942) against the target 2OFZ were identified. ZINC00003118440 is a theophylline derivative under the drug class 'bronchodilEtors' and further screening with approved bronchodilators was also studied to identify their ability to bind to the RNA binding region on the N protein. The other identified top hit is ZINC0000146942, which is a 3,4dihydropyrimidone class molecule. Hence this study suggests two important class of compounds, theophylline and pyrimidone derivaties as possible inhibitors of RNA binding to the N terminal domain of N protein of coronavirus, thus opening new avenues for in vitro validations.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32266867</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1538-0254</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Apr</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>Journal of biomolecular structure & dynamics</Title>
<ISOAbbreviation>J. Biomol. Struct. Dyn.</ISOAbbreviation>
</Journal>
<ArticleTitle>In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).</ArticleTitle>
<Pagination>
<MedlinePgn>1-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2020.1753580</ELocationID>
<Abstract>
<AbstractText>The N terminal domain (NTD) of Nucleocapsid protein (N protein) of coronavirus (CoV) binds to the viral (+) sense RNA and results in CoV ribonucleoprotien (CoV RNP) complex, essential for the virus replication. In this study, the RNA-binding N terminal domain (NTD) of the N protein was targeted for the identification of possible inhibitors of RNA binding. Two NTD structures of N proteins were selected (2OFZ and 1SSK, 92% homology) for virtual screening of 56,079 compounds from Asinex and Maybridge library to identify top 15 hits for each of the targets based on "docking score". These top-hits were further screened for MM-GBSA binding free energy, pharmacokinetic properties (QikProp) and drug-likeness (SwissADME) and subjected to molecular dynamics (MD) studies. Two suitable binders (ZINC00003118440 and ZINC0000146942) against the target 2OFZ were identified. ZINC00003118440 is a theophylline derivative under the drug class 'bronchodilEtors' and further screening with approved bronchodilators was also studied to identify their ability to bind to the RNA binding region on the N protein. The other identified top hit is ZINC0000146942, which is a 3,4dihydropyrimidone class molecule. Hence this study suggests two important class of compounds, theophylline and pyrimidone derivaties as possible inhibitors of RNA binding to the N terminal domain of N protein of coronavirus, thus opening new avenues for in vitro validations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sarma</LastName>
<ForeName>Phulen</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sekhar</LastName>
<ForeName>Nishant</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prajapat</LastName>
<ForeName>Manisha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Avti</LastName>
<ForeName>Pramod</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaur</LastName>
<ForeName>Hardeep</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Subodh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Sanjay</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Informatics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Harish</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prakash</LastName>
<ForeName>Ajay</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhibar</LastName>
<ForeName>Deba Prasad</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medhi</LastName>
<ForeName>Bikash</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-4017-641X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Biomol Struct Dyn</MedlineTA>
<NlmUniqueID>8404176</NlmUniqueID>
<ISSNLinking>0739-1102</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2019 novel corona virus</Keyword>
<Keyword MajorTopicYN="N">2019-nCoV</Keyword>
<Keyword MajorTopicYN="N">N terminal domain</Keyword>
<Keyword MajorTopicYN="N">Nucleocapsid protein</Keyword>
<Keyword MajorTopicYN="N">RNA binding</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">drug design</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32266867</ArticleId>
<ArticleId IdType="doi">10.1080/07391102.2020.1753580</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000296 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000296 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32266867
   |texte=   In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:32266867" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021